{"product_id":"cell-culture-market-by-product-consumables-media-reagents-sera-cell-lines-equipment-bioreactor-centrifuge-cell-counter-application-bioproduction-cancer-research-stem-cell-diagnostic-and-end-user-pharma-academic-global-forecast-to-2","title":"Cell Culture Market by Product [Consumables (Media, Reagents, Sera, Cell Lines), Equipment (Bioreactor, Centrifuge, Cell Counter)], Application (Bioproduction, Cancer Research, Stem Cell, Diagnostic), and End User (Pharma, Academic) - Global Forecast to 2","description":"\u003cp\u003eCell Culture Market by Product [Consumables (Media, Reagents, Sera, Cell Lines), Equipment (Bioreactor, Centrifuge, Cell Counter)], Application (Bioproduction, Cancer Research, Stem Cell, Diagnostic), and End User (Pharma, Academic) - Global Forecast to 2029\u003c\/p\u003e\n\n\u003cp\u003eCell Culture Market by Product [Consumables (Media, Reagents, Sera, Cell Lines), Equipment (Bioreactor, Centrifuge, Cell Counter)], Application (Bioproduction, Cancer Research, Stem Cell, Diagnostic), and End User (Pharma, Academic) - Global Forecast to 2029\u003c\/p\u003e\n\n\u003cp\u003eThe cell culture market is expected to reach $48.63 billion by 2029, at a CAGR of 11.7% from 2022 to 2029.\u003c\/p\u003e\n\n\u003cp\u003eAfter extensive primary and secondary research, the report provides an in-depth analysis of the cell culture market and insights into the key drivers, restraints, challenges, and opportunities in the cell culture market.\u003c\/p\u003e\n\n\u003cp\u003eThe growing demand for monoclonal bodies, increasing prevalence of chronic diseases, funding for cell-based research, rising adoption of single-use technologies, growing demand for biopharmaceuticals, and increasing R\u0026amp;D spending in the life science sector are the major factors driving the growth of this market. Furthermore, the growing adoption of 3D cell culture and personalized medicine to offer new growth potential are expected to provide significant growth opportunities. However, disposal of plastic waste generated from single-use technologies, cell line misidentification and cross contamination, and reproducibility of results challenge the growth of the market up to a certain extent.\u003c\/p\u003e\n\n\u003cp\u003eBased on product, in 2022, the consumables segment is estimated to account for the largest share of the cell culture market. The large market share of this segment is attributed to the recurrent usage of the consumables such as media, reagents, sera, and cell culture vessels for carrying out the cell culture technique. Additionally, companies are launching products specific to cell type, further supporting cell-specific research studies.\u003c\/p\u003e\n\n\u003cp\u003eBased on application, in 2022, the bioproduction segment is estimated to account for the largest share of the cell culture market. The large market share of this segment is attributed to the growing demand for biopharmaceutical products and the need for cell culture products for the bioprocessing of these biopharma products. Furthermore, research for novel products such as therapeutic proteins, vaccines, and cell and gene therapy contributes to market growth.\u003c\/p\u003e\n\n\u003cp\u003eBased on end user, in 2022, the pharmaceutical and biotechnology companies segment is estimated to account for the largest share of the cell culture market. The large market share of this segment is attributed to the increasing research and commercial production of biopharmaceuticals, increasing clinical pipeline, and rising funding for R\u0026amp;D related to cell-based therapies.\u003c\/p\u003e\n\n\u003cp\u003eAn in-depth analysis of the geographical scenario of the cell culture market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, the Middle East \u0026amp; Africa) along with the coverage of major countries in each region. In 2022, North America is estimated to account for the largest share of the cell culture market, followed by Europe, Asia-Pacific, Latin America, and the Middle East \u0026amp; Africa. The rising healthcare spending, new technologies and advancements in cell culture, increased demand for cell-based diagnosis and treatments, presence of major players, and availability of skilled professionals and best research institutes are the factors contributing to the large share of this regional market.\u003c\/p\u003e\n\n\u003cp\u003eThe key players operating in the cell culture market are Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), PromoCell GmbH (Germany), Cytiva (U.S.), Lonza Group Ltd (Switzerland), Corning Incorporated (U.S.), Becton, Dickinson and Company (U.S.), HiMedia Laboratories (India), Sartorius AG (Germany), Eppendorf SE (Germany), FUJIFILM Holdings Corporation (Japan), Agilent Technologies, Inc. (U.S.), Getinge AB (Sweden), Miltenyi Biotec B.V. \u0026amp; Co. KG (Germany), and Solida Biotech GmBH (Germany).\u003c\/p\u003e\n\n\u003cp\u003eScope of the Report:\u003c\/p\u003e\n\n\u003cp\u003eCell Culture Market, by Product\u003c\/p\u003e\n\n\u003cp\u003eConsumables\u003cbr\u003e\nMedia\u003c\/p\u003e\n\n\u003cp\u003eCell Culture Media Market, by Physical form\u003c\/p\u003e\n\n\u003cp\u003eDry Powder Media\u003cbr\u003e\nLiquid Media\u003c\/p\u003e\n\n\u003cp\u003eCell Culture Media Market, by Type\u003c\/p\u003e\n\n\u003cp\u003eOff-the-Shelf Media\u003cbr\u003e\nCustom Media\u003c\/p\u003e\n\n\u003cp\u003eCell Culture Media Market, by Source\u003c\/p\u003e\n\n\u003cp\u003eChemically Defined Media\u003cbr\u003e\nNatural Media\u003cbr\u003e\nSerum-free Media\u003cbr\u003e\nClassical Media and Salts\u003cbr\u003e\nStem Cell Culture Media\u003cbr\u003e\nSpecialty Media\u003cbr\u003e\nReagents\u003cbr\u003e\nGrowth Factors and Cytokines\u003cbr\u003e\nCryoprotective Reagents\u003cbr\u003e\nAntibiotics\/Antimycotics\u003cbr\u003e\nCell Dissociation Reagents\u003cbr\u003e\nBuffers\u003cbr\u003e\nBalanced Salt Solutions\u003cbr\u003e\nAttachment and Matrix Factors\u003cbr\u003e\nOther Cell Culture Reagents\u003c\/p\u003e\n\n\u003cp\u003e(Other cell culture reagents include chelators, antioxidants, sugars, vitamins, stains, and dyes)\u003c\/p\u003e\n\n\u003cp\u003eCells and Cell Lines\u003cbr\u003e\nSera\u003cbr\u003e\nFetal Bovine Serum\u003cbr\u003e\nOther Sera\u003c\/p\u003e\n\n\u003cp\u003e(Other sera include newborn calf serum, chicken serum, goat serum, rabbit serum, pig serum, mouse serum, sheep serum, rat serum, and horse serum)\u003c\/p\u003e\n\n\u003cp\u003eCell Culture Vessels\u003cbr\u003e\nCell Culture Dishes\u003cbr\u003e\nCell Culture Plates\u003cbr\u003e\nCell Culture Flasks\u003cbr\u003e\nRoller Bottles\u003c\/p\u003e\n\n\u003cp\u003eOther Cell Culture Vessels\u003c\/p\u003e\n\n\u003cp\u003e(Other cell culture vessels include pipettes, tips, cuvettes, and tubings)\u003c\/p\u003e\n\n\u003cp\u003eEquipment\u003cbr\u003e\nCryopreservative Containers\u003cbr\u003e\nRefrigerators and Freezers\u003cbr\u003e\nBiosafety Cabinets\u003cbr\u003e\nIncubators\u003cbr\u003e\nSterilizers\u003cbr\u003e\nBioreactors\u003cbr\u003e\nMicroscopes\u003cbr\u003e\nCentrifuges\u003cbr\u003e\nCell Counters\u003cbr\u003e\nWater Baths\u003cbr\u003e\nOther Equipment\u003c\/p\u003e\n\n\u003cp\u003e(Other equipment includes scales, weighing balance, and pH meter)\u003c\/p\u003e\n\n\u003cp\u003eCell Culture Market, by Application\u003c\/p\u003e\n\n\u003cp\u003eBioproduction\u003cbr\u003e\nMonoclonal Antibody Production\u003cbr\u003e\nTherapeutic Protein Production\u003cbr\u003e\nVaccine Production\u003cbr\u003e\nCell and Gene therapy\u003cbr\u003e\nDiagnostics\u003cbr\u003e\nCancer Research\u003cbr\u003e\nDrug Screening and Development\u003cbr\u003e\nStem Cell Research\u003c\/p\u003e\n\n\u003cp\u003eCell Culture Market, by End User\u003c\/p\u003e\n\n\u003cp\u003ePharmaceutical and Biotechnology Companies\u003cbr\u003e\nAcademic and Research Institutes\u003cbr\u003e\nDiagnostic Laboratories\u003c\/p\u003e\n\n\u003cp\u003eCell Culture Market, by Geography\u003c\/p\u003e\n\n\u003cp\u003eNorth America\u003cbr\u003e\nU.S.\u003cbr\u003e\nCanada\u003cbr\u003e\nEurope\u003cbr\u003e\nGermany\u003cbr\u003e\nFrance\u003cbr\u003e\nU.K.\u003cbr\u003e\nItaly\u003cbr\u003e\nSpain\u003cbr\u003e\nRest of Europe (RoE)\u003cbr\u003e\nAsia-Pacific (APAC)\u003cbr\u003e\nChina\u003cbr\u003e\nJapan\u003cbr\u003e\nIndia\u003cbr\u003e\nRest of APAC (RoAPAC)\u003cbr\u003e\nLatin America\u003cbr\u003e\nMiddle East \u0026amp; Africa Cell Culture Market - Report Summary   Report Metrics Details   Years Considered 2020 - 2029   Base Year 2022   Forecast Period 2022-2029   Page Count 338   Units Referenced Value (USD Million)   Segments\/Key Topics Market by Product, Market by Application, Market by End User, Market by Geography   Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East \u0026amp; Africa   Key Companies Mentioned Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), Cytiva (U.S.), Lonza Group Ltd. (Switzerland), Corning Incorporated (U.S.), Becton, Dickinson and Company (U.S.), Avantor, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), HiMedia Laboratories (India), Sartorius AG (Germany), Eppendorf SE (Germany), FUJIFILM Holdings Corporation (Japan), Agilent Technologies, Inc. (U.S.), Getinge AB (Sweden), Greiner Bio-One GmbH (Austria), and Miltenyi Biotec B.V. \u0026amp; Co. KG (Germany).\u003c\/p\u003e  \n\n\u003cp\u003eFAQs About the Report\u003c\/p\u003e\n\n\u003cp\u003eWhat is the focus of the cell culture market study?\u003c\/p\u003e\n\n\u003cp\u003eThe cell culture market study covers the market sizes \u0026amp; forecasts for various cell culture products used in the life science sector. The report involves the value analysis of various segments and subsegments of the cell culture market at the regional and country levels.\u003c\/p\u003e\n\n\u003cp\u003eWhat is the value of revenue generated from sale of cell culture products across the globe? At what rate is their demand expected to grow for the next 5-7 years?\u003c\/p\u003e\n\n\u003cp\u003eThe cell culture market is projected to reach $48.63 billion by 2029, at a CAGR of 11.7% during the forecast period.\u003c\/p\u003e\n\n\u003cp\u003eWhich product segment is estimated to hold the major share and register the highest growth rate in the cell culture market?\u003c\/p\u003e\n\n\u003cp\u003eBased on product, in 2022, the consumables segment is estimated to account for the largest share of the cell culture market. This segment is also projected to grow at the highest CAGR during the forecast period. The frequent use of these consumables drives the high growth rate of this segment. Additionally, continuous improvements in cell culture media contribute to the growth.\u003c\/p\u003e \n\n\u003cp\u003eWhich end-user segment of the cell culture market is projected to create more traction in the cell culture market?\u003c\/p\u003e\n\n\u003cp\u003eThe pharmaceutical \u0026amp; biotechnology companies segment is projected to register the highest CAGR during the forecast period. The growth of this segment is driven by the proliferation of pharmaceutical \u0026amp; biotechnology companies, rising unmet medical needs in the area of various chronic and rare diseases, and increasing demand for pharmaceutical \u0026amp; biopharmaceutical drugs from emerging countries.\u003c\/p\u003e\n\n\u003cp\u003eWhat are the key factors supporting the growth of this market? Also, what are the major opportunities for existing market players and new entrants in the cell culture market?\u003c\/p\u003e\n\n\u003cp\u003eThe growth of this market is driven by factors such as the growth in biopharmaceutical market, increasing prevalence of chronic diseases, growing demand for monoclonal antibodies, increase in research funding, and rising adoption of single-use technologies.\u003c\/p\u003e \n\n\u003cp\u003eIn addition, the growing adoption of 3D cell culture and personalized medicine to offer new growth potential are expected to provide significant opportunities for the growth of this market.\u003c\/p\u003e\n\n\u003cp\u003eWho are the major players operating in the cell culture market?\u003c\/p\u003e\n\n\u003cp\u003eThe key players operating in the cell culture market are Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), PromoCell GmbH (Germany), Cytiva (U.S.), Lonza Group Ltd (Switzerland), Corning Incorporated (U.S.), Becton, Dickinson and Company (U.S.), HiMedia Laboratories (India), Sartorius AG (Germany), Eppendorf SE (Germany), FUJIFILM Holdings Corporation (Japan), Agilent Technologies, Inc. (U.S.), Getinge AB (Sweden), Miltenyi Biotec B.V. \u0026amp; Co. KG (Germany), and Solida Biotech GmBH (Germany).\u003c\/p\u003e \n\n\u003cp\u003eWhich regions\/countries are expected to offer significant growth opportunities for the vendors operating in the cell culture market?\u003c\/p\u003e\n\n\u003cp\u003eEmerging economies from Asia-Pacific, such as China, are projected to offer significant growth opportunities for vendors operating in this market due to the presence of pharma \u0026amp; biopharma companies, increasing government funding and research \u0026amp; development activities in China, and the growth of CRO and CDMO in the country fostering growth in biotechnology innovations.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"December, 2022 \/ - \/ MCW16225335","offer_id":47645277684018,"sku":null,"price":5010.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/cell-culture-market-by-product-consumables-media-reagents-sera-cell-lines-equipment-bioreactor-centrifuge-cell-counter-application-bioproduction-cancer-research-stem-cell-diagnostic-and-end-user-pharma-academic-global-forecast-to-2","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}